ArticleBlood advances2023

Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL.

Maria Chiara Tisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.